Pli­ant calls it quits on Phase 2b id­io­path­ic pul­monary fi­bro­sis study

Pli­ant Ther­a­peu­tics has of­fi­cial­ly dis­con­tin­ued a mid-stage study of its chron­ic lung dis­ease treat­ment, less than a month af­ter the tri­al’s safe­ty board rec­om­mend­ed a …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER